1.
Murata S, Nakamura M, Sugihara K, Sakai T, Ishioka K, Takahashi S, Sasada S, Yasuda H, Fukunaga K. The Change in Neutrophil-to-lymphocyte Ratio after Initiation of Nivolumab Monotherapy May be a Strong Marker of Response and Predictor of Prognosis in Advanced Non-small Cell Lung Carcinoma. apjcc [Internet]. 8Mar.2022 [cited 20May2024];7(1):191-6. Available from: http://waocp.com/journal/index.php/apjcc/article/view/725